NASDAQ : MGTX
MeiraGTx Holdings plc — Key statistics
Healthcare · Biotechnology · United States
Last price 9.705 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 932.10M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 895.12M |
| Enterprise Value | 864.28M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 16, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 96.04M |
| Shares Outstanding | 96.04M |
| Shares Change (YoY) | +8.97% |
| Shares Change (QoQ) | +15.38% |
| Owned by Insiders (%) | 3.47% |
| Owned by Institutions (%) | 43.76% |
| Float | 53.83M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 9.93 |
| Forward PE | n/a |
| PS Ratio | 2.25 |
| Forward PS | 25.27 |
| PB Ratio | 4.07 |
| P/TBV Ratio | 4.16 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 65.39 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 10.94 |
| EV / Sales | 2.17 |
| EV / EBITDA | 4.41 |
| EV / EBIT | 4.70 |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 3.76 |
| Quick Ratio | 3.23 |
| Debt / Equity | 0.52 |
| Debt / EBITDA | 0.56 |
| Debt / FCF | n/a |
| Interest Coverage | 14.75 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 72.17% |
| Return on Assets (ROA) | 38.65% |
| Return on Invested Capital (ROIC) | 140.99% |
| Return on Capital Employed (ROCE) | 54.39% |
| Weighted Average Cost of Capital (WACC) | 11.58% |
| Revenue Per Employee | $1.01M |
| Profits Per Employee | $200,972 |
| Employee Count | 393 |
| Asset Turnover | 1.34 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 2.36M |
| Effective Tax Rate | 2.91% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.35 |
| 52-Week Price Change | +2.64% |
| 50-Day Moving Average | 11.61 |
| 200-Day Moving Average | 10.32 |
| Relative Strength Index (RSI) | 36.58 |
| Average Volume (20 Days) | 780,003 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 6.44M |
| Short Previous Month | 6.00M |
| Short % of Shares Out | 6.70% |
| Short % of Float | 11.96% |
| Short Ratio (days to cover) | 5.84 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 397.50M |
| Gross Profit | 389.35M |
| Operating Income | 184.03M |
| Pretax Income | 81.29M |
| Net Income | 78.98M |
| EBITDA | 196.13M |
| EBIT | 184.03M |
| Earnings Per Share (EPS) | $0.94 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 143.17M |
| Total Debt | 112.32M |
| Net Cash | 30.85M |
| Net Cash Per Share | $0.32 |
| Equity (Book Value) | 215.78M |
| Book Value Per Share | 2.29 |
| Working Capital | 160.25M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 13.69M |
| Capital Expenditures | -27.86M |
| Depreciation & Amortization | 12.10M |
| Net Borrowing | 24.94M |
| Free Cash Flow | -14.17M |
| FCF Per Share | -$0.15 |
Margins
| Measure | Value |
|---|
| Gross Margin | 97.95% |
| Operating Margin | 46.30% |
| Pretax Margin | 20.45% |
| Profit Margin | 19.87% |
| EBITDA Margin | 49.34% |
| EBIT Margin | 46.30% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -8.97% |
| Shareholder Yield | -8.97% |
| Earnings Yield | 10.07% |
| FCF Yield | -1.58% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $27.75 |
| Price Target Difference | 197.75% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 24.02% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 2.88 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |